Tag: Drug Approvals
FDA Approves Polypill Widaplik for Hypertension
Approval marks first triple-combination pill of telmisartan, amlodipine, and indapamide
Moderna’s New Lower-Dose COVID-19 Vaccine Approved by FDA
New vaccine represents a step forward in development of next-generation coronavirus vaccines
FDA Approves Tryptyr Eye Drops for Dry Eye Disease
Tryptyr works by stimulating corneal sensory nerves to increase natural tear production
FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and older
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa
FDA Delays Final Approval of Novavax COVID Vaccine
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombin
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placebo
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
Medication approved for uUTIs in women and pediatric patients aged 12 years and older
